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112A The Journal of Thoracic an341 Long-term tricuspid valve function after Norwood operation(continued on page 14A
d Cardiovascular Surgery c December 2011Maryam Elmi, BSc, Edward J. Hickey, MD, William G. Williams, MD,
Glen Van Arsdell, MD, Christopher A. Caldarone, MD, and Brian W. McCrindle, MD,
Toronto, Ontario, CanadaApproximately 25% of survivors require tricuspid valve surgery after Norwood palliation,
particularly those with mitral atresia or requiring lengthy clamp durations. Repair did not
compromise tricuspid performance, ventricular function, or late survival. However, several children
required late tricuspid intervention, which may have functional health implications and requires
further investigation.1348 Anatomic repair for congenitally corrected transposition of the great arteries:
A single-institution 19-year experience
Bari Murtuza, MD, PhD, David J. Barron, FRCS, Oliver Stumper, MD, PhD, John Stickley, BSc,
Donna Eaton, FRCS, Timothy J. Jones, FRCS, and William J. Brawn, FRCS, Birmingham,
United KingdomThere is significant morbidity after anatomic repair of ccTGA, which is higher in the DS than the
RS group. Nevertheless, the majority of patients are free of heart failure at 10 years, including high-
risk patients in severe heart failure before repair. Aortic annuloplasty may reduce risk of late aortic
insufficiency.1358 The impact of a dedicated single-ventricle home-monitoring program on
interstage somatic growth, interstage attrition, and 1-year survival
Christopher J. Petit, MD, Charles D. Fraser, MD, Raphael Mattamal, BS, Timothy C. Slesnick, MD,
Constance E. Cephus, MSN, and Elena C. Ocampo, MD, Houston, TexA dedicated home-monitoring program for infants with single-ventricle heart disease does not
reduce interstage mortality but improves 1-year transplant-free survival. Infants followed under the
single-ventricle program demonstrated improved interstage somatic growth.1367 The evolving role of intraoperative balloon pulmonary valvuloplasty in
valve-sparing repair of tetralogy of Fallot
Joshua D. Robinson, MD, Rahul H. Rathod, MD, David W. Brown, MD, Pedro J. Del Nido, MD,
James E. Lock, MD, Doff B. McElhinney, MD, Emile A. Bacha, MD, and Audrey C. Marshall, MD,
Boston, MassThis study investigated the role of intraoperative balloon pulmonary valvuloplasty in achieving
valve-sparing repair for tetralogy of Fallot. Despite being used in patients with more hypoplastic
valves, balloon valvuloplasty resulted in similar longitudinal annular growth and pulmonary
regurgitation as the traditional methods, but higher rates of reintervention.1374 Long-term results of pulmonary artery rehabilitation in patients with
pulmonary atresia, ventricular septal defect, pulmonary artery hypoplasia,
and major aortopulmonary collaterals
Andreea Dragulescu, MD, PhD, Issam Kammache, MD, Virginie Fouilloux, MD,
Pascal Amedro, MD, Dominique Metras, MD, Bernard Kreitmann, MD, PhD, and
Alain Fraisse, MD, PhD, Marseille and Montpellier, FranceTwenty children with pulmonary atresia, ventricular septal defect, pulmonary artery hypoplasia
(mean Nakata index, 266 14mm2/m2), and major aortopulmonary collaterals underwent 3 steps of
pulmonary rehabilitation, including right ventricle to pulmonary artery connection, interventional
catheterizations, and surgical repair after significant pulmonary artery growth (mean Nakata index,
208 6 85 mm2/m2), with 16 long-term survivors.)











S114A The Journal of Thoracic an381 Mitral valve dysplasia syndrome: A unique form of left-sided heart disease(continued on page 16A
d Cardiovascular Surgery c December 2011Lindsay S. Rogers, MD, Amy L. Peterson, MD, J. William Gaynor, MD, Jonathan J. Rome, MD,
Paul M. Weinberg, MD, and Jack Rychik, MD, Philadelphia, PaMitral valve dysplasia syndrome is a distinct form of congenital heart disease with aortic stenosis
and an arcade-type mitral valve. This disease has significant neonatal mortality. Unique
characteristics predicative of unstable transitional circulation at birth and overall mortality are
identifiable by fetal echocardiography.1388 Transpulmonary arterial repair of type 1 ventricular septal defect will induce
pulmonary regurgitation: Appraisal of subpulmonic approach
Shao-Ju Chien, MD, Jen-Ping Chang, MD, Chi-Di Liang, MD, Ying-Jui Lin, MD,
Chien-Fu Huang, MD, I-Chun Lin, MD, and Chiung-Lun Kao, MD, Taiwan, Republic of ChinaA transpulmonary arterial approach to repair type I VSD is the standard. However, the possible
adverse effect on the pulmonary valve has not been investigated. We highlight the development of
late pulmonary regurgitation after transpulmonary arterial repair of type I VSD. Therefore,
a subpulmonic approach is advocated as an alternative.General Thoracic
Surgery (GTS)
1393 A prospective controlled trial of endobronchial ultrasound-guided
transbronchial needle aspiration compared with mediastinoscopy for
mediastinal lymph node staging of lung cancer
Kazuhiro Yasufuku, MD, PhD, Andrew Pierre, MD, MSc, Gail Darling, MD, Marc de Perrot, MD,
MSc, Thomas Waddell, MD, PhD, Michael Johnston, MD, Gilda da Cunha Santos, MD, PhD,
William Geddie, MD, Scott Boerner, MD, Lisa W. Le, MSc, and Shaf Keshavjee, MD, MSc,
Toronto, Ontario, CanadaEndobronchial ultrasound-guided transbronchial needle aspiration is a minimally invasive lymph
node sampling modality capable of sampling mediastinal and hilar lymph nodes. A comparison of
endobronchial ultrasound-guided transbronchial needle aspiration with mediastinoscopy for
mediastinal lymph node staging of non–small cell lung cancer resulted in no significant differences
in determining true pathologic N stage.Commentary 1400 Mediastinoscopy: An obsolete procedure?
Valerie W. Rusch, MD, New York, NY1403 Esophageal submucosa: The watershed for esophageal cancer
Siva Raja, MD, PhD, Thomas W. Rice, MD, John R. Goldblum, MD, Lisa A. Rybicki,
MS, Sudish C. Murthy, MD, PhD, David P. Mason, MD, and Eugene H. Blackstone, MD,
Cleveland, OhioSubmucosal cancer characteristics and lymphatic anatomy create a watershed for regional lymph
node metastases in the deep submucosa. This previously unrecognized divide distinguishes
superficial submucosal cancers with good survival from deep submucosal cancers with poor
survival. Aggressive therapy of more superficial cancers is critical before submucosal invasion
occurs.)











S116A The Journal of Thoracic an412 Video-assisted thoracoscopic surgery (VATS) lobectomy: Catastrophic
intraoperative complications(continued on page 18A
d Cardiovascular Surgery c December 2011Raja M. Flores, MD, Ugonna Ihekweazu, MD, Joseph Dycoco, BA, Nabil P. Rizk, MD,
Valerie W. Rusch, MD, Manjit S. Bains, MD, Robert J. Downey, MD, David Finley, MD,
Prasad Adusumilli, MD, Inderpal Sarkaria, MD, James Huang, MD, and Bernard Park, MD,
New York, NY, and Hackensack, NJCatastrophic intraoperative complications of VATS lobectomy are uncommon. However,
awareness of the possibility of such injuries is critical to avoid them, and development of specific
management strategies is necessary to limit morbidity should they occur.1418 Inefficiency as the major driver of excess costs in lung resection
Donald E. Fry, MD, Michael Pine, MD, MBA, Barbara L. Jones, MA, and Roger J. Meimban, PhD,
Chicago, Ill, and Albuquerque, NMAdverse outcomes and costs for lung resection were determined from claims data to identify
reference performing hospitals. Only 5.1% of hospitals were quality outliers, whereas 15.8% were
cost outliers. Excess costs were primarily driven by inefficiency and not by excessive adverse
events.Acquired Cardiovascular
Disease (ACD)
1423 Improved midterm outcomes for type A (central) pulmonary emboli treated
surgically
James P. Greelish, MD, Marzia Leacche, MD, Natalia S. Solenkova, MD, PhD,
Rashid M. Ahmad, MD, and John G. Byrne, MD, Nashville, TennWe propose a simplified anatomic classification for pulmonary emboli that algorithmically defines
those who might be best treated with surgical pulmonary embolectomy (type A) from those best
treated medically (type B).1430 Valve sparing-root replacement with the reimplantation technique to increase
the durability of bicuspid aortic valve repair
Laurent de Kerchove, MD, Munir Boodhwani, MD, MMSC, David Glineur, MD,
Michel Vandyck, MD, Jean-Louis Vanoverschelde, MD, PhD, Philippe Noirhomme, MD, and
Gebrine El Khoury, MD, Brussels, Belgium, and Ottawa, Ontario, CanadaTo assess the role of root stabilization in bicuspid aortic valve repair, we performed a matched
comparison between valve repair with the reimplantation technique versus subcommissural
annuloplasty or no annuloplasty. The results showed an improved durability with the reimplantation
technique with no increase of perioperative morbidity.1439 Pulmonary hypertension adversely affects short- and long-term survival after
mitral valve operation for mitral regurgitation: Implications for timing of
surgery
Mehrdad Ghoreishi, MD, Charles F. Evans, MD, Christopher R. DeFilippi, MD,
Gerald Hobbs, PhD, Cindi A. Young, Bartley P. Griffith, MD, and James S. Gammie, MD,
Baltimore, Md, and Morgantown, WVaSystolic pulmonary artery pressure was measured in 873 consecutive patients undergoing surgery
for mitral regurgitation. Preoperative systolic pulmonary artery pressure of 40 mm Hg or greater
had a negative impact on both short- and long-term survival after MVoperation. MVoperation
should be performed before the development of pulmonary hypertension.)











S118A The Journal of Thoracic an453 Effect of sutureless implantation of the Perceval S aortic valve bioprosthesis on
intraoperative and early postoperative outcomes(continued on page 19A
d Cardiovascular Surgery c December 2011Willem Flameng, MD, PhD, Marie-Christine Herregods, MD, PhD, Hadewich Hermans, MD,
Gerry Van der Mieren, MD, Monique Vercalsteren, RN, Gert Poortmans, MD,
Jan Van Hemelrijck, MD, PhD, and Bart Meuris, MD, PhD, Leuven, BelgiumWith the Perceval S (Sorin Biomedica Cardio Srl, Sallugia, Italy) sutureless aortic valve, it is
possible to implant a well-functioning sutureless stent-mounted valve in the aortic position in less
than 20 minutes of aortic crossclamping. This is associated with excellent early clinical and
hemodynamic outcome in high-risk patients.1458 Repair of Stanford type A aortic dissection with ascending aorta and hemiarch
replacement combined with stent-graft elephant trunk technique by using
innominate cannulation
Enyi Shi, MD, PhD, Tianxiang Gu, MD, PhD, Lei Yu, MD, Zongyi Xiu, MD,
Zhiwei Zhang, MD, PhD, Chun Wang, MD, PhD, and Qin Fang, MD, PhD, Shenyang, ChinaForty-six patients with acute type A dissection without involvement of 3 vessels of the arch
underwent replacement of the ascending aorta and hemiarch combined with stent-graft elephant
trunk implantation by using innominate artery cannulation. The preliminary outcomes were
encouraging with a mean follow-up of 13.7 6 7.4 months.1464 Revascularization of the left anterior descending artery area using a single left
internal thoracic artery: Auto-Y composite grafting or sequential bypassing
Won-Chul Cho, MD, Joon Bum Kim, MD, Sung Ho Jung, MD, Seung Hyun Lee, MD,
Cheol Hyun Chung, MD, Suk Jung Choo, MD, and Jae Won Lee, MD, Seoul, KoreaWe examined outcomes following the use of a single LITA for revascularization of the LAD and
a diagonal branch artery through auto-Y composite or sequential grafting. Both techniques showed
excellent clinical and patency outcomes.1469 Surgical treatment of pulmonary artery sarcoma
Hui-Li Gan, MD, PhD, Jian-Qun Zhang, MD, Qi-Wen Zhou, MD, Wei Xiao, MD,
Yuan-Ming Gao, MD, Shuang Liu, MD, and Pi-Shan Wang, MD, Beijing ChinaNine patients with pulmonary artery sarcoma were surgically treated. Radical surgical resection
provides the only chance of survival for these patients, and distal embolectomy may further extend
survival.1473 Early and long-term results of reoperative total aortic root replacement with
reimplantation of the coronary arteries
Ismail El-Hamamsy, MD, PhD, Michael Ibrahim, BA (Cantab), Louis-Mathieu Stevens, MD,
Herbert Witzke, MD, Lucy Clark, PhD, and Magdi H. Yacoub, FRS, Montreal, Quebec, Canada,
and London, United KingdomThere is continuing concern regarding the risks and long-term results of reoperation after total
replacement of the aortic root with reimplantation of the coronary arteries. We reviewed our total
experience with this procedure and found that reoperative aortic root replacement can be performed
safely with good short-term and midterm outcomes.)





L1478 Femoral artery cannulation for thoracic aortic surgery: Safe under
transesophageal echocardiographic control(continued on page 20A
The Journal of Thoracic and Cardiovascular Surgery c Volume 142, Number 6 19AEDBassem Ayyash, MD, Maryann Tranquilli, RN, and John A. Elefteriades, MD,
New Haven, ConnCH
DThis large experience in the transesophageal echocardiographic era strongly supports femoral
cannulation for aortic surgery, with good survival, low stroke rate, minimal perfusion-related
rupture or dissection, and minimal limb ischemia. If intraoperative transesophageal
echocardiography shows mobile atheroma, axillary cannulation is preferred.1482 Complete removal as a routine treatment for any cardiovascular implantable
electronic device–associated infection
Maximilian Pichlmaier, MA, MD, Ludmilla Knigina, MD, Ingo Kutschka, MD,
Christoph Bara, MD, Hanno Oswald, MD, Gunnar Klein, MD, Theodosius Bisdas, MD, and
Axel Haverich, MD, PhD, Hannover, GermanyG
TSThe frequency of bacterial infections of pacemakers and implantable cardioverter defibrillators is
increasing and associated with significant morbidity and mortality. Complete explantation of all
system components in both local pocket infection and lead endocarditis is safe and shows the
highest success rate in eradication infection. The acceptance of the radical approach by patients and
health care facilities is good.1491 Results of matching valve and root repair to aortic valve and root pathology
Lars G. Svensson, MD, PhD, Lillian H. Batizy, MS, Eugene H. Blackstone, MD,
A. Marc Gillinov, MD, Michael C. Moon, MD, Richard S. D’Agostino, MD,
Edward M. Nadolny, CCP, William J. Stewart, MD, Brian P. Griffin, MD, Donald F. Hammer, MD,
Richard Grimm, DO, and Bruce W. Lytle, MD, Cleveland, Ohio, and Burlington, MassD
A
CAortic root pathology combined with regurgitation may be associated with different causes, such as
connective tissue disorders, bicuspid valves, aortic dissection, and degenerative aneurysms, but
with careful matching of appropriate root and valve-preserving operative procedures to pathology,
excellent long-term outcomes can be achieved without valve replacement.1499 Aortic no-touch technique makes the difference in off-pump coronary artery
bypass grafting
Maximilian Y. Emmert, MD, Burkhardt Seifert, PhD, Markus Wilhelm, MD, J€urg Gr€unenfelder,
MD, Volkmar Falk, MD, and Sacha P. Salzberg, MD, Zurich, SwitzerlandPMBoth off-pump surgery and aortic no-touch technique reduce stroke after CABG. Here we evaluate
the impact of partial aortic clamping versus a no-touch technique using either total arterial
revascularization or the HEARTSTRING system on the incidence of stroke. Total arterial
revascularization remains the method of choice, but whenever a proximal anastomosis is needed,
a clampless technique should be applied.1507 A minimally invasive approach is more cost-effective than a traditional
sternotomy approach for mitral valve surgery
Alexander Iribarne, MD, MS, Rachel Easterwood, BA, Mark J. Russo, MD, MS,
Y. ClaireWang, MD, ScD, Jonathan Yang, MD, Kimberly N. Hong, MHSA, Craig R. Smith, MD, and
Michael Argenziano, MD, New York, NY, and Chicago, IllT/
B
SEIn this analysis we assess the cost-effectiveness of a minimally invasive versus traditional
sternotomy approach formitral valve surgery.We demonstrate that theminimally invasive approach
is associated with lower total hospital costs and equivalent efficacy across a range of measures.)













120A The Journal of Thoracic an515 Cardiac magnetic resonance imaging for the assessment of ventricular
function, geometry, and viability before and after surgical ventricular
reconstruction(continued on page 22A
d Cardiovascular Surgery c December 2011Jan H€uther, Torsten Doenst, MD, PhD, Stefan Nitzsche, MD, Holger Thiele, MD, PhD,
Friedrich-WilhelmMohr, MD, PhD, andMatthias Gutberlet, MD, PhD, Leipzig and Jena, GermanyWe assessed CMR-derived parameters as potential predictors of functional recovery in 24 patients
before and after SVR. Comparing patients with good recovery with patients with poor recovery
showed that the assessment of basal scar tissue and the determination of the AVI may identify the
subgroup of patients potentially benefitting from SVR.1523 Standardized preoperative corticosteroid treatment in neonates undergoing
cardiac surgery: Results from a randomized trial
Eric M. Graham, MD, Andrew M. Atz, MD, Ryan J. Butts, MD, Nathaniel L. Baker, MS,
Sinai C. Zyblewski, MD, Rachael L. Deardorff, MS, Stacia M. DeSantis, PhD, Scott T. Reeves, MD,
Scott M. Bradley, MD, and Francis G. Spinale, MD, PhD, Charleston, SCCombined preoperative and intraoperative use of methylprednisolone in neonatal cardiac surgery
does not favorably affect early clinical outcomes.1530 Impact of preoperative left ventricular function and time from infarction on
the long-term benefits after intramyocardial CD1331 bone marrow stem cell
transplant
Can Yerebakan, MD, Alexander Kaminski, MD, Bernd Westphal, MD, Peter Donndorf, MD,
Aenne Glass, PhD, Andreas Liebold, MD, Christof Stamm, MD, and Gustav Steinhoff, MD,
Rostock and Berlin, GermanyLong-term clinical and functional results of 35 patients after intramyocardial stem cell treatment
during CABG and 20 after CABG alone were compared. Stem cell treatment revealed excellent
long-term safety and was most effective in patients with preoperative LVEF not greater than 40%
operated on 7 to 12 weeks after infarction.1540 Lack of neurologic improvement after aortic repair for acute type A aortic
dissection complicated by cerebral malperfusion: Predictors and association
with survival
Naoto Morimoto, MD, Kenji Okada, MD, and Yutaka Okita, MD, Kobe, JapanTime to surgery and baseline National Institutes of Health Stroke Scale score were predictors of
lack of neurologic improvement after aortic repair for acute type A aortic dissection complicated by
cerebral malperfusion. The lack of neurologic improvement was associated with poor survival.Evolving Technology/
Basic Science (ET/BS)
1545 A novel cardioport for beating-heart, image-guided intracardiac surgery
Nikolay V. Vasilyev, MD, Mitsuhiro Kawata, MD, PhD, Christopher M. DiBiasio, PhD,Keith V. Durand, PhD, Jonathan Hopkins, PhD, Zachary J. Traina, MS, Alexander H. Slocum, PhD,
and Pedro J. del Nido, MD, Boston and Cambridge, MassA universal cardioport that prevents potential complications of transcardiac beating-heart
procedures, such as air embolism and bleeding, was designed. The port was tested ex vivo and
in vivo in pigs and was shown to improve safety of beating-heart procedures.)











S122A The Journal of Thoracic an552 Eight hours of cold static storage with adenosine and lidocaine (Adenocaine)
heart preservation solutions: Toward therapeutic suspended animation(continued on page 24A
d Cardiovascular Surgery c December 2011Donna M. Rudd, MSc, and Geoffrey P. Dobson, PhD, Townsville, Queensland, AustraliaWe report a 78% return of cardiac output after 8 hours of cold static storage (4C) using
normokalemic, polarizing adenosine, lidocaine, melatonin, and insulin solution in the isolated
rat heart compared with 55% cardiac output with AL cardioplegia alone, 4% cardiac output
with Custodiol-HTK preservation solution, and 25% cardiac output with Celsior preservation
solution.1562 A fetal goat model of cardiopulmonary bypass with cardioplegic arrest and
hemodynamic assessment
Xiao-bing Liu, MD, Cheng-bin Zhou, MD, Ji-mei Chen, MD, Jian-zheng Cen, MD, Gang Xu, MD,
and Jian Zhuang, MD, Guangzhou and Shenzhen, Guangdong, People’s Republic of ChinaWe present a reproducible fetal goat model of CPB with cardioplegic arrest for 30 minutes
with short-term survival of the fetuses in 11 experimental animals. This fetal goat model is suitable
to study clinically relevant problems related to fetal CPB, myocardial protection, and
hemodynamics.1567 Bone marrow–derived MCP1 required for experimental aortic aneurysm
formation and smooth muscle phenotypic modulation
Christopher W. Moehle, MS, Castigliano M. Bhamidipati, DO, Matthew R. Alexander, MS,
Gaurav S. Mehta, MBBS, James N. Irvine, BS, Morgan Salmon, PhD, Gilbert R. Upchurch, Jr, MD,
Irving L. Kron, MD, Gary K. Owens, PhD, and Gorav Ailawadi, MD, Charlottesville, VaMonocyte chemotactic protein 1 is required for aortic aneurysm formation and smooth muscle
phenotypic modulation in an elastase perfusion model. Knockout selectively in bone marrow-
derived cells is protective and shows a surprising added benefit versus global knockout. Monocyte
chemotactic protein 1 acts directly on aortic smooth muscle cells to reduce contractile proteins and
induce matrix metalloproteinases.Cardiothoracic
Imaging
1575 Calcified amorphous tumor of left atrium
Yi-Chang Lin, MD, Yi-Ting Tsai, MD, and Chien-Sung Tsai, MD, Taipei, TaiwanBrief Technique Reports 1577 Minimally invasive aortic valve replacement via right anterior
minithoracotomy: Early outcomes and midterm follow-up
Mattia Glauber, MD, Antonio Miceli, MD, Stefano Bevilacqua, MD, and
Pier A. Farneti, MD, Massa, Italy1579 Split, in situ left internal thoracic artery to revascularize left anterior
descending coronary artery system
Dusko Nezic, MD, PhD, FETCS, Zelimir Antonic, MD, Aleksandar Knezevic, MD, BcS, and
Zeljko Bojovic, MD, Belgrade, Serbia1581 Rescue surgery for bronchial obstruction after endovascular
thoracoabdominal stent implantation
Philipp Kiefer, MD, Joerg Seeburger, MD, Lukas Lehmkuhl, MD, and
Friedrich Wilhelm Mohr, MD, PhD, Leipzig, Germany)











S124A The Journal of Thoracic an582 Right ventricular exclusion for a neonatal patient with Ebstein anomaly: A free
wall resection of the right ventricle(continued on page 26A
d Cardiovascular Surgery c December 2011Takuya Kawabata, MD, PhD, Shingo Kasahara, MD, PhD, Sadahiko Arai, MD, PhD, and
Shunji Sano, MD, PhD, Okayama, JapanBrief Research Report 1585 Consequences of mitral valve prolapse on chordal tension: Ex vivo and in vivo
studies in large animal models
Mathieu Granier, MD, MSc, Morten O. Jensen, PhD, Jesper L. Honge, MD, Alain Bel, MD,
Philippe Menasche, MD, PhD, Sten L. Nielsen, MD, PhD, DMSc, Alain Carpentier, MD, PhD,
Robert A. Levine, MD, and Albert A. Hagege, MD, PhD, Paris, France, Aarhus, Denmark, and
Boston, MassOnline Only: Brief
Clinical Report
e205 Intraoperative occlusion of left coronary ostium after aortic repair detected by
transesophageal echocardiography
Kazumasa Orihashi, MD, Taiichi Takasaki, MD, Masamichi Ozawa, MD, and Taijiro Sueda, MD,
Hiroshima, JapanLetters to the Editor 1588 The hazard of comparing apples and oranges: The proper indication for the use
of recombinant activated clotting factor VII in cardiac surgery
Vincenzo Tarzia, MD, Tomaso Bottio, MD, PhD, Edward Buratto, MD, Luca Spiezia, MD,
Paolo Simioni, MD, and Gino Gerosa, MD, Padova, Italy1589 Reply to the Editor
J. Matthew Toole, MD,Walter E. Uber, PharmD, and John S. Ikonomidis, MD, PhD, Charleston, SC1589 Cannulation sites and types for antegrade cerebral perfusion during arch
surgery
Bingyang Ji, MD, Xiaohua Wang, MD, Jinping Liu, MD, and Cun Long, MD, Beijing, People’s
Republic of China1590 Reply to the Editor
Enyi Shi, MD, PhD, and Tianxiang Gu, MD, PhD, Shenyang, China1591 Dabigatran etexilate in mechanical valve thromboprophylaxis
Mihalis E. Argiriou, MD, Athens, Greece1591 Reply to the Editor
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